<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>RDW&#8217;nin bir &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/rdwnin-bir/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 22:39:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>RDW&#8217;nin bir &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Can Red Blood Cell Width Predict T-Cell Lymphoma Outcomes?</title>
		<link>https://bioengineer.org/can-red-blood-cell-width-predict-t-cell-lymphoma-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 22:39:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hematologic Malignancy]]></category>
		<category><![CDATA[Hematological malignancy outcomes]]></category>
		<category><![CDATA[inflammation biomarkers]]></category>
		<category><![CDATA[İşte 5 uygun etiket]]></category>
		<category><![CDATA[Makalenin içeriğine ve odak noktalarına göre uygun 5 etiket: **Peripheral T-cell lymphoma]]></category>
		<category><![CDATA[Patient Outcomes** **Açıklama:** 1. **Red Blood Cell Distribution Width:** Makalenin temel araştırma konusu olan RDW'yi doğrudan belirtir. 2. **Per]]></category>
		<category><![CDATA[Peripheral T-Cell Lymphoma]]></category>
		<category><![CDATA[Personalized cancer therapy** * **Peripheral T-cell lymphoma:** Makalenin ana konusu olan spesifik lenfoma tipi. * **RDW prognostic marker:** Çalışmanın temel bulgusu]]></category>
		<category><![CDATA[prognostic biomarker]]></category>
		<category><![CDATA[RDW prognostic marker]]></category>
		<category><![CDATA[RDW'nin bir]]></category>
		<category><![CDATA[virgülle ayrılmış halde: **Red Blood Cell Distribution Width]]></category>
		<guid isPermaLink="false">https://bioengineer.org/can-red-blood-cell-width-predict-t-cell-lymphoma-outcomes/</guid>

					<description><![CDATA[In recent months, significant attention has been directed toward the role of red blood cell distribution width (RDW) as a potential prognostic factor in various medical conditions. Among the myriad of studies conducted, a fresh investigation spearheaded by Lan, Zhao, and Sun has shone a light on peripheral T-cell lymphoma (PTCL), a type of cancer [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320033</post-id>	</item>
	</channel>
</rss>
